77.44
price up icon6.02%   4.40
after-market アフターアワーズ: 78.65 1.21 +1.56%
loading
前日終値:
$73.04
開ける:
$74.88
24時間の取引高:
66,908
Relative Volume:
1.33
時価総額:
$477.80M
収益:
-
当期純損益:
$-7.12M
株価収益率:
-33.67
EPS:
-2.3
ネットキャッシュフロー:
$-6.82M
1週間 パフォーマンス:
+16.89%
1か月 パフォーマンス:
+154.57%
6か月 パフォーマンス:
+106.07%
1年 パフォーマンス:
+1,398%
1日の値動き範囲:
Value
$68.16
$79.80
1週間の範囲:
Value
$60.43
$79.80
52週間の値動き範囲:
Value
$4.50
$79.80

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Name
名前
Monopar Therapeutics Inc
Name
セクター
Healthcare (1143)
Name
電話
(847) 388-0349
Name
住所
1000 SKOKIE BLVD SUITE 350, WILMETTE
Name
職員
16
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
MNPR's Discussions on Twitter

MNPR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MNPR
Monopar Therapeutics Inc
77.44 450.65M 0 -7.12M -6.82M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-09 開始されました BTIG Research Buy
2025-09-03 開始されました Oppenheimer Outperform
2025-09-03 開始されました Raymond James Strong Buy
2025-08-26 再開されました H.C. Wainwright Buy
2025-07-07 開始されました Cantor Fitzgerald Overweight
2025-06-23 開始されました Chardan Capital Markets Buy
2025-03-19 再開されました Piper Sandler Overweight
2025-01-10 開始されました Piper Sandler Overweight
2024-10-11 開始されました Rodman & Renshaw Buy
2021-01-28 開始されました ROTH Capital Buy
すべてを表示

Monopar Therapeutics Inc (MNPR) 最新ニュース

pulisher
04:33 AM

Monopar Therapeutics stock price target raised to $95 by Piper Sandler - Investing.com India

04:33 AM
pulisher
03:17 AM

Monopar Therapeutics Announces Underwriting Agreement for Stock Sale - MSN

03:17 AM
pulisher
01:33 AM

Piper Sandler Raises Monopar Therapeutics (MNPR) Price Target to - GuruFocus

01:33 AM
pulisher
08:39 AM

MNPR: BTIG Raises Price Target on Monopar Therapeutics to $104 | - GuruFocus

08:39 AM
pulisher
08:35 AM

Monopar Therapeutics (MNPR): Chardan Capital Raises Price Target - GuruFocus

08:35 AM
pulisher
07:48 AM

Chardan Raises Price Target on Monopar Therapeutics to $85 From $60, Keeps Buy Rating - MarketScreener

07:48 AM
pulisher
05:31 AM

Goldman Sachs Group Inc. Takes $673,000 Position in Monopar Therapeutics Inc. $MNPR - Defense World

05:31 AM
pulisher
Sep 24, 2025

Monopar Therapeutics stock price target raised to $104 by BTIG - Investing.com UK

Sep 24, 2025
pulisher
Sep 24, 2025

Positive Outlook for Monopar Therapeutics’ ALXN1840 Amid New Copper Balance Findings - TipRanks

Sep 24, 2025
pulisher
Sep 24, 2025

Lake Street Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $106 - 富途牛牛

Sep 24, 2025
pulisher
Sep 24, 2025

Monopar Therapeutics (MNPR) Sees Share Increase Amid Positive St - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Monopar jumps after doctor letter in Journal of Hepatology - TipRanks

Sep 24, 2025
pulisher
Sep 24, 2025

How to integrate Monopar Therapeutics Inc. into portfolio analysis toolsEarnings Performance Report & Risk Managed Investment Entry Signals - newser.com

Sep 24, 2025
pulisher
Sep 24, 2025

Monopar Therapeutics Prices $135 Million Offering of Common Stock, Pre-Funded Warrants - MarketScreener

Sep 24, 2025
pulisher
Sep 24, 2025

Monopar Therapeutics (MNPR) Launches $100M Stock Offering - GuruFocus

Sep 24, 2025
pulisher
Sep 23, 2025

Monopar Therapeutics prices $100 million stock offering - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Announces Pricing Of $19.2 Mln Public Offering Of Common Stock - Nasdaq

Sep 23, 2025
pulisher
Sep 23, 2025

$135 Million Raise: Biotech Monopar Therapeutics Prices Major Stock Offering with $35M Buyback Plan - Stock Titan

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - The Manila Times

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients - The Manila Times

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Therapeutics announces pricing of $135 million underwritten offering of common stock and pre-funded warrants - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Breakthrough: -0.367mg Daily Copper ReductionMonopar's Drug Shows Promise for Wilson Disease Patients - Stock Titan

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Therapeutics Inc. Reports Peer-Reviewed Publication Highlighting ALXN1840's Efficacy in Improving Copper Balance for Wilson Disease Patients - Quiver Quantitative

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire Inc.

Sep 23, 2025
pulisher
Sep 23, 2025

Monopar Announces Journal of Hepatology Publishes - GlobeNewswire

Sep 23, 2025
pulisher
Sep 23, 2025

Lake Street Initiates Coverage of Monopar Therapeutics (MNPR) with Buy Recommendation - Nasdaq

Sep 23, 2025
pulisher
Sep 23, 2025

Lake Street Initiates Monopar Therapeutics at Buy With $106 Price Target - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Full technical analysis of Monopar Therapeutics Inc. stockEarnings Miss & Community Supported Trade Ideas - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Monopar Therapeutics (MNPR) Hosts Virtual Meeting with Piper San - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

Risk adjusted return profile for Monopar Therapeutics Inc. analyzed2025 Major Catalysts & Verified High Yield Trade Plans - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Using portfolio simulators with Monopar Therapeutics Inc. includedGap Down & Stepwise Trade Signal Implementation - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Monopar Therapeutics Inc.(NasdaqCM: MNPR) added to S&P Global BMI Index - MarketScreener

Sep 21, 2025
pulisher
Sep 21, 2025

Monopar Therapeutics Hits New 52-Week High of $54.54 - Markets Mojo

Sep 21, 2025
pulisher
Sep 21, 2025

Monopar Therapeutics (NASDAQ:MNPR) Given "Buy" Rating at Chardan Capital - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Aug Fed Impact: Can DXLG keep up with sector leadersTrade Exit Summary & Real-Time Volume Triggers - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Can volume confirm reversal in Monopar Therapeutics Inc.Earnings Summary Report & Detailed Earnings Play Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

BTIG Research Reaffirms "Buy" Rating for Monopar Therapeutics (NASDAQ:MNPR) - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Analyzing Monopar Therapeutics Inc. with risk reward ratio chartsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Forecast Cut: How liquid is MMSI stock2025 Momentum Check & Risk Adjusted Buy/Sell Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Analyzing recovery setups for Monopar Therapeutics Inc. investorsDay Trade & Community Consensus Trade Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Breakouts Watch: Does Skeena Resources Limited have declining or rising EPS2025 Volatility Report & Capital Efficiency Focused Ideas - khodrobank.com

Sep 19, 2025
pulisher
Sep 18, 2025

Macro Review: Does Monopar Therapeutics Inc stock have upside surprise potentialOil Prices & Weekly Return Optimization Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Can trapped investors hope for a rebound in Monopar Therapeutics Inc.July 2025 Summary & High Yield Equity Trading Tips - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

What MACD and RSI say about Monopar Therapeutics Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Monopar Therapeutics Stock Soars to New 52-Week High of $58.94 - Markets Mojo

Sep 18, 2025
pulisher
Sep 18, 2025

Monopar Therapeutics Hits New 52-Week High at $68.18 - Markets Mojo

Sep 18, 2025
pulisher
Sep 18, 2025

Understanding Monopar Therapeutics Inc.’s price movementSell Signal & Weekly Return Optimization Plans - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Stop Loss: Will Monopar Therapeutics Inc benefit from sector rotationFed Meeting & Reliable Volume Spike Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Quarterly Recap: What is Pearson plc Depositary Receipts 5 year growth outlookEarnings Miss & Low Risk Growth Stock Ideas - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛

Sep 17, 2025
pulisher
Sep 17, 2025

Is Monopar Therapeutics Inc. stock ready for a breakoutGDP Growth & Safe Entry Trade Reports - newser.com

Sep 17, 2025

Monopar Therapeutics Inc (MNPR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Monopar Therapeutics Inc (MNPR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
STARR CHRISTOPHER M
Director
Jul 14 '25
Sale
40.00
16,800
672,020
5,173
Robinson Chandler
Chief Executive Officer
Jul 14 '25
Sale
40.00
16,800
672,020
73,472
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):